Press release content from Business Wire. The AP news staff was not involved in its creation.
Renzo DiCarlo of BioPharma Services Inc. Presents COVID-19 Vaccine Strategies to Canadian Parliament
April 27, 2021 GMT
TORONTO (BUSINESS WIRE) Apr 27, 2021
Renzo DiCarlo, CEO of BioPharma Services Inc. was proud to be invited to appear as a witness before the House of Commons’ Standing Committee on International Trade, in view of its study entitled
.
As a London School of Economics (LSE) alumnus in stakeholder theory research with 25 years of experience in Pharmaceutical GMP and Medical research, Renzo DiCarlo is uniquely qualified to comment on Canada’s future strategy to manage COVID-19, vaccination cycles and the Variants of Concern (VOC) that are now appearing.